CF
BNTX icon

Cantor Fitzgerald’s BioNTech BNTX Stock Holding History

Cantor Fitzgerald’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,899
Closed -$1.65M – 267
2024
Q1 		$1.65M Buy
+17,899
New +$1.72M 0.39% 44
2023
Q1 		– Sell
-3,074
Closed -$462K – 676
2022
Q4 		$462K Buy
3,074
+205
+7% +$31.5K 0.01% 473
2022
Q3 		$387K Buy
+2,869
New +$439K 0.01% 538
2022
Q2 		– Sell
-1,310
Closed -$223K – 817
2022
Q1 		$223K Buy
+1,310
New +$220K 0.02% 251

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cantor Fitzgerald's BNTX Position: Q2 2024 in Review

Cantor Fitzgerald sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 17,899 shares — an estimated $1.65M sold.

Cantor Fitzgerald first reported a position in BNTX in Q1 2022 and held it in 4 quarters. The position peaked at $1.65M in Q1 2024. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Cantor Fitzgerald reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 17,899 BioNTech shares in Q2 2024, an estimated $1.65M.
  • Cantor Fitzgerald first reported a position in BioNTech in Q1 2022 and held it in 4 quarters.
  • Cantor Fitzgerald's BioNTech position peaked at $1.65M in Q1 2024.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.